Osivax was founded by Alexandre Le Vert, Dr Florence Nicolas, Dr Fergal Hill in 2017.

Who are Osivax's investors?

Osivax's investors include Wellcome Trust, Start Capital, CAP HORN VC.

Where is Osivax headquartered?

Osivax is headquartered in Lyon, FR.

Osivax

Lyon, FR · Founded 2017 · 60 employees on LinkedIn · 3 known investors

Find your way into Osivax

256 people in our graph share verified history with the Osivax team — schools, employers, funds. One of them is your warm intro.

Tom Beauvironnetunlockedknows Alexandre Le Vert · together at Osivax (overlapped)

×11knows the team · via École Polytechnique

Osivax develops vaccines targeting conserved internal viral structures to provide broader and longer-lasting protection against influenza, leveraging its proprietary oligoDOM technology platform. The company originated from research co-developed with the University of Oxford and is supported by public health foundations and pharmaceutical partners.

Biotech Healthtech Medical Devices

Founders & leadership

Osivax was founded in 2017 by Alexandre Le Vert, Dr Florence Nicolas, and Dr Fergal Hill.

Alexandre Le Vert Executive Chairman & Co-FounderAlexandre Le Vert holds a Master's in Cellular Biology from Harvard University and a Master's in Engineering Sciences from École Polytechnique. He has held leadership roles including CEO at Imaxio, where he refocused the company on vaccine development, and Investment Director at Pradeyrol Développement; he currently serves as Executive Chairman and Co-Founder of Osivax.

Dr Florence NicolasChief Scientific Officer & Co-Founder

Dr Fergal HillCo-founder

Investors · 3

Wellcome Trust✓ verifiedLondon

Start Capital

CAP HORN VCreportedParis · $1.1M – $22M

In the news

Osivax Receives $19.5M BARDA Award to Advance Next-Generation Influenza Vaccine for Pandemic and Seasonal Preparednessfinance.yahoo.com · Aug 2025

Osivax Secures Strategic Funding to Accelerate the Development of its Influenza Vaccine Candidatesbusinesswire.com · Mar 2025

Osivax Raises Strategic Fundingfinsmes.com · Mar 2025

Osivax - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does Osivax do?: Osivax develops vaccines targeting conserved internal viral structures to provide broader and longer-lasting protection against influenza, leveraging its proprietary oligoDOM technology platform. The company originated from research co-developed with the University of Oxford and is supported by public health foundations and pharmaceutical partners.
Who founded Osivax?: Osivax was founded by Alexandre Le Vert, Dr Florence Nicolas, Dr Fergal Hill in 2017.
Who are Osivax's investors?: Osivax's investors include Wellcome Trust, Start Capital, CAP HORN VC.
Where is Osivax headquartered?: Osivax is headquartered in Lyon, FR.